Vialase Announces Publication of 24-Month Safety Data from First-in-Human Study of Femtosecond Laser Image-Guided High-Precision Trabeculotomy (FLigHT)

Outcomes Reported in Ophthalmology® Science Indicate Favorable Safety Profile for Novel, Noninvasive Glaucoma Treatment ALISA VIEJO, CA — April 18, 2023 — ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm with the development of a truly noninvasive image-guided femtosecond laser treatment to enhance glaucoma […] The post Vialase Announces Publication of 24-Month Safety Data from First-in-Human Study of Femtosecond Laser Image-Guided High-Precision Trabeculotomy (FLigHT) appeared first on Vialase .